Extended Data Fig. 8: Full distribution of [18F]AZD4694 SUVR and CSF Aβ 42/40 grouped by Braak stage.
From: Biomarker modeling of Alzheimer’s disease using PET-based Braak staging

Group means are represented by lines, error bars indicate standard deviation. Note that the CSF biomarkers represent a subsample of individuals (n = 189 individuals with CSF evaluations) which did not include the amyloid-PET negative individuals at Braak stage VI (n = 324 individuals with amyloid-PET).